Episil-Precision Inc (3016) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Episil-Precision Inc TWD 277, price TWD 160, upside +72.9%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Episil-Precision Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 27.10 TWD – 160.00 TWD · fair‑value band 250.26 TWD – 276.56 TWD · the 160.00 TWD price screens below the 276.56 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Episil-Precision in your weekly email
Every Wednesday you see whether Episil-Precision is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Episil-Precision Inc. engages in the development, manufacturing, and sale of silicon epitaxy wafers and compound semiconductor epitaxial wafers in Taiwan, Japan, China, and internationally.
Show more
Episil-Precision Inc. engages in the development, manufacturing, and sale of silicon epitaxy wafers and compound semiconductor epitaxial wafers in Taiwan, Japan, China, and internationally. The company offers buried-layer epitaxy wafers, multi-layer epitaxy wafers, silicon epitaxy on SOI (silicon on insulator) wafers, GaN epitaxial wafers, and silicon carbide (SiC) epitaxial wafers for applications in high-power field effect transistors, diodes, and insulation; and power components, such as gate bipolar transistors (IGBTs) and power management ICs (PMICs). Its products are used in various industries comprising consumer electronics, automotive electronics, industrial control manufacturing, telecommunications, and computers. The company was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. Episil-Precision Inc. is a subsidiary of Episil Technologies Inc.
Stock analysis
Episil-Precision Inc (3016) currently trades at 160.00 TWD, while our model-based Fair Value estimate is 276.56 TWD, implying the stock looks roughly 42.1% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 24 models at a data quality of 95/100, which puts the evidence level at medium.
Scenario range: 250.26 TWD (bear) to 276.56 TWD (bull), the price of 160.00 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Episil-Precision Inc reported revenue of 3.9B TWD in FY2025 versus 5.0B TWD in FY2021, a compound −6.3%/yr. Reported net income was 20.4M TWD in FY2025, compounding −51.9%/yr from FY2021.
Key figures
Market cap 46.7B TWD (≈ $1.5B) · P/S ratio 8.11 · EPS (TTM) 0.0700 TWD · Dividend yield 0.3% · Net margin 0.5% · Return on equity 2.4% · Return on assets (EBIT) 4.5% · Operating margin 10.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 239% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −34% fair-value upside, at 73%, 3016 screens cheaper than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (0.7400 TWD to 32.05 TWD). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 250.26 TWDFair Value 276.56 TWDBull 276.56 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−5.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.7%
Start year 2020 (pandemic). Over 10 years: +17.4% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−5.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.5%
Dividend (yield on the price)0.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6% vs −6%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1% → 0%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductor Equipment & Materials · 216 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Episil-Precision Inc Fair Value". https://www.fairvalue-calculator.com/stock/3016
Frequently asked questions
Is Episil-Precision Inc (3016) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 276.56 TWD versus a price of 160.00 TWD, about +73% upside (undervalued).
What is the fair value of 3016?
Our model-based fair value for Episil-Precision Inc is 276.56 TWD (as of Sep 23, 2026), built from audited fundamentals. The current price: 160.00 TWD.
What is the quality score of 3016?
Episil-Precision Inc has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Episil-Precision Inc (3016)?
Our model-based price target is the fair value of 276.56 TWD (as of Sep 23, 2026) from 23 valuation models. Cautious scenario 250.26 TWD, optimistic scenario 276.56 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Episil-Precision Inc stock forecast for 2026?
Our models put fair value at 276.56 TWD, about +73% upside versus a price of 160.00 TWD (undervalued). Cautious scenario 250.26 TWD, optimistic scenario 276.56 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Episil-Precision Inc (3016)?
Episil-Precision Inc reported trailing-twelve-month revenue of about 4.1B TWD (latest available figure, as of Sep 23, 2026).
Does Episil-Precision Inc pay a dividend?
Episil-Precision Inc currently shows a dividend yield of about 0.31% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of Episil-Precision Inc (3016)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Episil-Precision Inc it is 276.56 TWD per share (as of Sep 23, 2026), against a price of 160.00 TWD. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Episil-Precision Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 3016 trades below its calculated fair value: price 160.00 TWD, fair value 276.56 TWD, a gap of about +73% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3016?
No. The price is what the market pays today (160.00 TWD); the fair value is what the company's own numbers justify (276.56 TWD). For Episil-Precision Inc the two are 116.56 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Episil-Precision Inc worth?
The market values Episil-Precision Inc at about 46.7B TWD (market capitalisation, as of Sep 23, 2026). Per share that is 160.00 TWD; our models calculate a fair value of 276.56 TWD per share.
What do the bullish and bearish scenarios say about 3016?
Our models span a range for Episil-Precision Inc: cautious scenario 250.26 TWD, base 276.56 TWD, optimistic 276.56 TWD per share (as of Sep 23, 2026, price 160.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Episil-Precision Inc (3016)?
Balance-sheet figures for Episil-Precision Inc (as of Sep 23, 2026): return on equity 2.4%, debt of 0.10 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 3016 from its 52-week high?
Episil-Precision Inc trades at 160.00 TWD, at its 52-week high of 160.00 TWD and 239% above the low of 47.20 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 276.56 TWD is for.
Which stocks are comparable to Episil-Precision Inc?
From the same area (Technology) we also value ASML Holding, Applied Materials, Inc, Lam Research Corporation, KLA Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Episil-Precision Inc stock attractive at the current price?
The data as of Sep 23, 2026: price 160.00 TWD, calculated fair value 276.56 TWD (+73%), Quality Score 51/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3016 calculated?
We run Episil-Precision Inc through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 276.56 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Episil-Precision Inc currently trades 73 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Episil-Precision Inc (3016)?
The closing price on Sep 24, 2026 was 160.00 TWD. Our model-based fair value is 276.56 TWD, about +73% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Episil-Precision Inc right now?
The price is below even our cautious bear case (250.26 TWD). The market is more pessimistic than our downside scenario. Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality. The models converge in a tight band (250.26 TWD to 276.56 TWD), unusually little disagreement for a valuation.
Key figures of Episil-Precision Inc
How large is the market capitalisation of Episil-Precision Inc (3016)?
The market capitalisation of Episil-Precision Inc is 46.7B TWD (≈ $1.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Episil-Precision Inc (3016)?
The price-to-sales ratio of Episil-Precision Inc is 8.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Episil-Precision Inc (3016)?
Earnings per share at Episil-Precision Inc are 0.0700 TWD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Episil-Precision Inc (3016)?
The dividend yield of Episil-Precision Inc is 0.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Episil-Precision Inc (3016)?
The net margin of Episil-Precision Inc is 0.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Episil-Precision Inc (3016)?
The return on equity (ROE) of Episil-Precision Inc is 2.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Episil-Precision Inc (3016)?
On an EBIT basis the return on assets of Episil-Precision Inc is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Episil-Precision Inc (3016)?
The operating margin of Episil-Precision Inc is 10.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Episil-Precision Inc (3016)?
Revenue at Episil-Precision Inc is growing +18.1% versus a year earlier (3y avg −12.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Episil-Precision Inc (3016)?
Earnings per share at Episil-Precision Inc are growing +34.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Episil-Precision Inc (3016) generate?
The free cash flow of Episil-Precision Inc is 43.1M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Episil-Precision Inc (3016) hold?
Episil-Precision Inc holds more cash than debt, 1.2B TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Episil-Precision Inc in the live analysis
One click puts Episil-Precision Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
